Bivariate Sensitivity Analyses

(A) The sensitivity of our estimates of the efficacy of Q to changes in the compliance rate and to changes in θ, the proportion of infections that are either asymptomatic or presymptomatic.

(B) The sensitivity of our estimates of the efficacy of QIA to changes in the delay in the delivery of drugs to quarantined households and to changes in the delay in the isolation of individuals.

All other parameters are held constant at their baseline values (see Figure 1 and Table 1).